Follicle inhibition at the primordial stage without increasing apoptosis, with a combination of everolimus, verapamil-Reference-Cited by-同舟云学术

Follicle inhibition at the primordial stage without increasing apoptosis, with a combination of everolimus, verapamil

Published:2020-10-20 Issue:11 Volume:47 Page:8711-8726
ISSN:0301-4851
Container-title:Molecular Biology Reports
language:en
Short-container-title:Mol Biol Rep

Author:

Pargianas Michail^ORCID,Kosmas Ioannis^ORCID,Papageorgiou Kyriaki,Kitsou Chrysoula,Papoudou-Bai Alexandra^ORCID,Batistatou Anna,Markoula Sofia,Salta Styliani^ORCID,Dalkalitsis Alexandros^ORCID,Kolibianakis Stratis^ORCID,Tarlatzis Basil C.^ORCID,Georgiou Ioannis,Michaelidis Theologos M.^ORCID

Funder

NSRF

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11033-020-05917-2.pdf

Reference72 articles.

1. Inoki K, Li Y, Zhu T, Wu J, Guan KL (2002) TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 4(9):648–657. https://doi.org/10.1038/ncb839

2. Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC (2002) Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3- kinase/akt pathway. Mol Cell 10(1):151–162. https://doi.org/10.1016/s1097-2765(02)00568-3

3. Dan HC, Sun M, Yang L, Feldman RI, Sui XM, Ou CC, Nellist M, Yeung RS, Halley DJ, Nicosia SV, Pledger WJ, Cheng JQ (2002) Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J Biol Chem 277(38):35364–35370. https://doi.org/10.1074/jbc.M205838200